Current Assets Veränderung Datum
AbbVie USD 33.22B 4.37B 2023-09
Acadia Pharmaceuticals USD 616.12M 116.96M 2023-12
Agios Pharmaceuticals USD 833.83M 129.48M 2023-12
ALKERMES USD 1.46B 67.43M 2023-09
Alnylam Pharmaceuticals USD 2.98B 2.76M 2023-12
Amgen USD 30.33B 18.14B 2023-12
Biogen USD 6.86B 1.59B 2023-12
BioMarin Pharmaceutical USD 2.96B 780K 2023-12
Cytokinetics USD 628.05M 66.63M 2023-12
Dynavax Technologies USD 859.12M 23.45M 2023-12
Enanta Pharmaceuticals USD 422.79M 25.67M 2023-09
Exelixis USD 1.44B 147.16M 2023-09
Gilead Sciences USD 16.45B 474M 2023-12
Halozyme Therapeutics USD 746.42M 132.58M 2023-12
Incyte USD 4.65B 242.74M 2023-12
Intra Cellular Therapies USD 667.8M 34.63M 2023-12
Ionis Pharmaceuticals USD 2.64B 57.2M 2023-12
Nektar Therapeutics USD 399.02M 42.03M 2023-09
Neurocrine Biosciences USD 1.65B 153.3M 2023-09
Pfizer USD 74.01B 665M 2023-09
Regeneron Pharmaceuticals USD 24.49B 5.85B 2023-12
Repligen USD 978.46M 20.13M 2023-09
Rigel Pharmaceuticals USD 95.02M 5.9M 2023-09
Sarepta Therapeutics USD 2.45B 21.76M 2023-09
Teva Pharmaceutical Industries USD 11.42B 663M 2023-09
Ultragenyx Pharmaceutical USD 599.19M 102.95M 2023-09
Vertex Pharmaceuticals USD 14.7B 822.9M 2023-09
Xoma USD 34.5M 3.92M 2023-09



Neurocrine Biosciences Umlaufvermögen - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2024.